VANGUARD GROUP INC - FIBROGEN INC ownership

FIBROGEN INC's ticker is FGEN and the CUSIP is 31572Q808. A total of 187 filers reported holding FIBROGEN INC in Q3 2017. The put-call ratio across all filers is 3.13 and the average weighting 0.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of FIBROGEN INC
ValueSharesWeighting
Q3 2023$7,818,687
-70.3%
9,060,943
-7.0%
0.00%
-100.0%
Q2 2023$26,297,876
-84.0%
9,739,954
+10.3%
0.00%
-75.0%
Q1 2023$164,779,557
+8.9%
8,830,630
-6.5%
0.00%0.0%
Q4 2022$151,293,986
+19.4%
9,444,069
-3.0%
0.00%0.0%
Q3 2022$126,729,000
+24.1%
9,740,942
+0.7%
0.00%
+33.3%
Q2 2022$102,134,000
-9.1%
9,671,867
+3.4%
0.00%0.0%
Q1 2022$112,387,000
-11.8%
9,349,957
+3.5%
0.00%0.0%
Q4 2021$127,411,000
+49.7%
9,036,188
+8.5%
0.00%
+50.0%
Q3 2021$85,133,000
-59.5%
8,329,947
+5.5%
0.00%
-60.0%
Q2 2021$210,214,000
-22.3%
7,893,858
+1.3%
0.01%
-28.6%
Q1 2021$270,490,000
-3.6%
7,792,851
+3.0%
0.01%
-12.5%
Q4 2020$280,584,000
-7.4%
7,564,946
+2.7%
0.01%
-20.0%
Q3 2020$303,017,000
-0.9%
7,369,115
-2.4%
0.01%
-9.1%
Q2 2020$305,921,000
+23.5%
7,548,004
+5.9%
0.01%0.0%
Q1 2020$247,730,000
-17.8%
7,128,944
+1.4%
0.01%
+10.0%
Q4 2019$301,449,000
+11.8%
7,028,427
-3.6%
0.01%0.0%
Q3 2019$269,725,000
-18.0%
7,293,812
+0.2%
0.01%
-16.7%
Q2 2019$328,780,000
-16.2%
7,277,118
+0.8%
0.01%
-20.0%
Q1 2019$392,447,000
+18.7%
7,220,740
+1.1%
0.02%0.0%
Q4 2018$330,509,000
-21.4%
7,141,519
+3.2%
0.02%
-6.2%
Q3 2018$420,503,000
-1.2%
6,921,874
+1.8%
0.02%
-11.1%
Q2 2018$425,472,000
+42.0%
6,796,688
+4.8%
0.02%
+38.5%
Q1 2018$299,667,000
+3.6%
6,486,273
+6.3%
0.01%0.0%
Q4 2017$289,262,000
-15.4%
6,102,565
-3.9%
0.01%
-18.8%
Q3 2017$341,727,000
+82.1%
6,351,796
+9.4%
0.02%
+77.8%
Q2 2017$187,612,000
+50.8%
5,808,439
+15.1%
0.01%
+50.0%
Q1 2017$124,409,000
+24.9%
5,047,018
+8.4%
0.01%0.0%
Q4 2016$99,601,000
+6.6%
4,654,240
+3.1%
0.01%
+20.0%
Q3 2016$93,416,000
+34.9%
4,512,857
+6.9%
0.01%
+25.0%
Q2 2016$69,254,000
-16.2%
4,220,201
+8.8%
0.00%
-20.0%
Q1 2016$82,615,000
-24.4%
3,880,466
+8.2%
0.01%
-28.6%
Q4 2015$109,292,000
-70.1%
3,586,867
-73.1%
0.01%
-50.0%
Q3 2015$366,059,000
+531.2%
13,326,910
+440.1%
0.01%
+250.0%
Q2 2015$57,992,000
+285.2%
2,467,714
+414.3%
0.00%
+300.0%
Q1 2015$15,056,000
+3581.2%
479,799
+3104.9%
0.00%
Q4 2014$409,00014,9710.00%
Other shareholders
FIBROGEN INC shareholders Q3 2017
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 605,713$9,703,5225.73%
ARMISTICE CAPITAL, LLC 3,864,000$61,901,2801.08%
Logos Global Management LP 525,000$8,410,5000.98%
5AM Venture Management, LLC 225,583$3,613,8400.97%
Intercontinental Wealth Advisors, LLC 191,300$3,064,6260.91%
BHK Investment Advisors, LLC 87,550$1,402,5510.79%
Integral Health Asset Management, LLC 175,000$2,803,5000.59%
Nan Fung Group Holdings Ltd 34,106$546,3780.38%
Soleus Capital Management, L.P. 113,463$1,817,6770.26%
Point72 Asset Management, L.P. 4,781,645$76,601,9530.26%
View complete list of FIBROGEN INC shareholders